The global naltrexone and buprenorphine market size was estimated at USD 4.17 billion in 2024 and is projected to reach USD 9.80 billion by 2033, growing at a CAGR of 9.25% from 2025 to 2033. The market is expected to grow due to the increasing prevalence of substance use disorders and g... Read More »
July 2025The global dupixent market size was estimated at USD 14.15 billion in 2024, and is projected to reach USD 27.58 billion by 2033, growing at a CAGR of 7.70% from 2025 to 2033. The Dupixent industry reflects a transition from traditional therapies to biologics. Anchored by its innovative interleukin-4 and interleukin-... Read More »
July 2025The global diabetic ketoacidosis treatment market size was estimated at USD 874.51 million in 2024 and is projected to reach USD 1,272.36 million by 2033, growing at a CAGR of 4.26% from 2025 to 2033. This strong growth trajectory is propelled by the escalating global prevalence of diabe... Read More »
July 2025The U.S. Tremfya market size was estimated at USD 3.00 billion in 2024 and is projected to reach USD 4.89 billion by 2033, growing at a CAGR of 5.32% from 2025 to 2033. The rising incidence of chronic plaque psoriasis and psoriatic arthritis in the U.S. is contributing to increased deman... Read More »
July 2025The global lysosomal storage disease treatment market size was estimated at USD 4.54 billion in 2024 and is projected to reach USD 6.68 billion by 2033, growing at a CAGR of 4.54% from 2025 to 2033, driven by rising diagnostic capabilities, advancements in enzyme replacement and gene the... Read More »
July 2025The U.S. allergy diagnostics & therapeutics market size was valued at USD 10.86 billion in 2024 and is projected to grow at a CAGR of 6.8% from 2025 to 2030. The market is driven by the increasing prevalence of allergies among the population, and environmental factors such as increas... Read More »
June 2025The global tremfya market size was estimated at USD 3.67 billion in 2024 and is projected to reach USD 7.29 billion by 2033, growing at a CAGR of 7.60% from 2025 to 2033. The increasing prevalence of chronic plaque psoriasis and psoriatic arthritis drives greater demand for advanced biol... Read More »
June 2025The U.S. androgenetic alopecia market was valued at USD 979.1 million in 2024 and is expected to grow at a CAGR of 6.6% from 2025 to 2030. The increasing incidence of Androgenic Alopecia (AGA) is driving market growth. Androgenetic alopecia, the most common form of hair loss, affects a s... Read More »
June 2025The global herbal supplements market size was estimated at USD 42.33 billion in 2024 and is anticipated to reach USD 90.24 billion in 2033, growing at a CAGR of 8.89% from 2025 to 2033. This growth is driven by rising consumer health consciousness, a growing preference for natural and pl... Read More »
June 2025The global infant nutrition market size was valued at USD 392.1 million in 2024 and is projected to reach USD 611.1 million by 2030, growing at a CAGR of 7.7% from 2025 to 2030. The market growth is driven by factors such as increasing awareness and acceptance of infant nutrition product... Read More »
June 2025The global rozanolixizumab (Rystiggo) market size was estimated at USD 218.61 million in 2024 and is projected to reach USD 1,700.40 million by 2033, growing at a CAGR of 15.22% from 2025 to 2033. The increasing prevalence of chronic plaque psoriasis and psoriatic arthritis drives greate... Read More »
June 2025The U.S. keytruda market size was estimated at USD 17.87 billion in 2024 and is projected to decline at a CAGR of -3.12% from 2025 to 2033. The market faces challenges from the impending patent expiration in 2028, introducing biosimilar competition. Although the decline is expected, mark... Read More »
June 2025The U.S. anti-aging supplements market was valued at USD 1.39 billion in 2024 and is expected to grow at a CAGR of 7.2% from 2025 to 2030. Growth is driven by increasing health consciousness, rising life expectancy, and a proactive approach to age-related health management among U.S. con... Read More »
June 2025The U.S. Rozanolixizumab (Rystiggo) market size was estimated at USD 199.13 million in 2024 and is expected to grow at a CAGR of 7.30% from 2025 to 2033. The U.S. Rozanolixizumab (Rystiggo) market focuses on treating generalized myasthenia gravis (gMG) in adults with anti-AChR or anti-Mu... Read More »
June 2025The global liver disease therapeutics market size was estimated at USD 20.31 billion in 2024 and is projected to reach USD 40.29 billion by 2033, growing at a CAGR of 7.9% from 2025 to 2033. Rising cases of NAFLD, hepatitis, and alcohol-related liver conditions, advancements in drug... Read More »
June 2025The Germany pharmaceutical market size was estimated at USD 95.11 billion in 2024 and is expected to grow at a CAGR of 5.31% from 2025 to 2033. The growth is driven by advances in digital health technologies supporting drug development and personalized medicine, such as AI and genome seq... Read More »
June 2025The U.S. active pharmaceutical ingredients CDMO market was valued at USD 25.28 billion in 2024 and is projected to reach USD 33.86 billion by 2030, growing at a CAGR of 5.1% from 2025 to 2030. This growth is driven by rising demand for advanced pharmaceutical manufacturing services to su... Read More »
June 2025The U.S. ultomiris drug market size was estimated at USD 1.46 billion in 2024 and is projected to reach USD 8.14 billion by 2033, growing at a CAGR of 19.93% from 2025 to 2033. Ultomiris continues to gain traction due to its extended dosing interval, which improves patient compliance and... Read More »
June 2025The global onychomycosis market was estimated at USD 3.81 billion in 2024 and is projected to reach USD 5.74 billion by 2033, growing at a CAGR of 4.7% from 2025 to 2033. The market is driven by the rising prevalence of fungal nail infections, increasing incidence of chronic conditions s... Read More »
June 2025The global peanut allergy treatment market size was estimated at USD 536.8 million in 2024 and is projected to reach USD 1,461.5 million by 2033, growing at a CAGR of 11.43% from 2025 to 2033. This market is witnessing robust expansion, fueled by rising peanut allergy prevalence and inno... Read More »
June 2025